Glucose monitoring and glucose lowering agents for children and young people with type 2 diabetes: summary of updated NICE guidance

What you need to knowRefer children and young people with suspected or diagnosed type 2 diabetes (T2DM) to a specialist paediatric diabetes team to ensure appropriate diagnosis, investigation, and treatment, including a continuing programme of education on how diet, physical activity, and reducing body weight can improve glycaemic controlCapillary blood glucose monitoring is now recommended for all children and young people with T2DM, and continuous glucose monitoring for people treated with insulinSpecialists should consider offering liraglutide or dulaglutide, or alternatively empagliflozin, in combination with metformin to lower blood glucoseType 2 diabetes mellitus (T2DM) in children and young people (aged under 18 years) is a more aggressive disease than in older adults and is associated with higher risk of severe long term and potentially life threatening complications (eg, cardiovascular disease, renal disease) compared with other types of diabetes. The worldwide prevalence and annual incidence of T2DM in children and young people…
Read Original Article: Glucose monitoring and glucose lowering agents for children and young people with type 2 diabetes: summary of updated NICE guidance »